Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Nicole Concin, MD, PhD, highlights key data for endometrial and ovarian cancers presented at the ESGO 2021 annual meeting, including:
Department of Gynaecology and Obstetrics
Medical University Innsbruck
Consultant in Gynaecological Oncology
Department of Gynaecology and Gynaecologocial Oncology
KEM Evang. Kliniken Essen-Mitte
This program has been made available online.
Experts review key data for ovarian, endometrial, and cervical cancers from the 2022 SGO, ASCO, ESMO, IGCS, and ESGO meetings, from Clinical Care Options (CCO)
Expert commentary on HRD testing, PARP inhibitor, and quality-of-life studies in rare ovarian cancer from the 2022 ESGO Congress, from Clinical Care Options (CCO)
Podcast episode with expert thoughts on studies of interest presented at the 2022 ESGO annual meeting in Berlin, Germany, from Clinical Care Options (CCO)
Podcast with transmasculine cancer survivor Yee Won Chong and gynecologic oncologist Dr Norma Steiner discussing their insights on cancer care for transgender patients, from Clinical Care Options (CCO)